Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 4

Association of Angiotensin II Type 1 ReceptorA1166C Gene Polymorphisms with Coronary ArteryDisease in Thrace Region of Turkey

Pages
337–342
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients harboring these genetic variants should be under close supervision for the devel opment of CAD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Although the risk factors for coronary artery disease (CAD) are well established, a significant gap still exists inunderstanding the pathology of atherosclerotic heart disease evolving without conventional risk factors.
📊
Key Findings & Data:Therefore, geneticfactors are considered to play a significant role in this setting.
💡
Conclusion & Impact:Patients harboring these genetic variants should be under close supervision for the devel opment of CAD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Although the risk factors for coronary artery disease (CAD) are well established, a significant gap still exists inunderstanding the pathology of atherosclerotic heart disease evolving without conventional risk factors. Therefore, geneticfactors are considered to play a significant role in this setting. The present study aimed to assess the relationship betweenangiotensin 2 type 1 receptor (AT1R) A1166C gene polymorphism and CAD. Materials and Methods: Patients with documented CAD (n=121) were compared with controls with normal coronaryarteries (n=121). CAD was diagnosed using a coronary angiography. The median age of participants was 59±12 years withan equal sex distribution. A comparison between the two groups with regard to the AT1R A1166C gene polymorphism wasmade through the amplification of DNA using polymerase chain reaction. Results: This study demonstrated that adenine-adenine and cytosine-cytosine (CC) genotypes were more frequent, yetadenine-cytosine genotype was less frequent among patients with CAD compared with controls [p=0.003), 95% confidenceinterval (CI)]. The AT1R A1166C gene polymorphism along with the CC genotype and C allele was found to be associatedwith CAD. Further, gender, hypertension, family history, age, and low levels of serum high-density lipoprotein also had asignificant relationship with AT1R A1166C gene polymorphism. Conclusion: The present study suggested AT1R A1166C gene polymorphism, CC genotype, and C allele as potential riskfactors for atherosclerotic CAD. Patients harboring these genetic variants should be under close supervision for the devel opment of CAD.

🔖

Cite This Article

ÖZKALAYCI, F., SİVRİ, N., PALABIYIK, O., TAYLAN, G., AKSOY, Y., YILMAZTEPE, M. A. (2022). Association of Angiotensin II Type 1 ReceptorA1166C Gene Polymorphisms with Coronary ArteryDisease in Thrace Region of Turkey. Erciyes Medical Journal, Cilt: 43 - Sayı: 4, 337–342. https://ajindex.com/articles/502246

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Li Y, Li X, Jia N, Guo S, Chu S, Niu W. Meta-analysis of the association between angiotensin II receptor, Type 1 gene A1166C polymorphism and coronary artery disease in Chinese populations. J Renin Angiotensin Aldosterone Syst 2013; 14(1): 82–90
  2. Zhai C, Cong H, Zhang H, Hou K, Zhang Y, Zhang Y. M235T polymorphism in the angiotensinogen gene and cardiovascular disease: An updated meta-analysis of 39 case-control comparisons. Anatol J Cardiol 2019; 21(4): 222–32
  3. Ozturk O, Ozturk U, Nergiz S, Karahan MZ. The relationship between angiotensin-II Type 1 receptor gene polymorphism and repolarization parameters after a first anterior acute myocardial infarction. Korean Circ J 2016; 46(6): 791–7
  4. Zhang Y, Yang T, Zhou W, Huang Y. A meta-analysis on the association of genetic polymorphism of the angiotensin-converting enzyme and coronary artery disease in the chinese population. Rev Assoc Med Bras 2019; 65(6): 923–9
  5. Al-Jafari AA, Daoud MS, Ataya FS. Renin-angiotensin system gene polymorphisms and coronary artery disease in Saudi patients with diabetes mellitus. Int J Clin Exp Pathol 2017; 10(10): 10505–14
  6. Ghafil FA, Mohammad BI, Al-Janabi HS, Hadi NR, Al-Aubaidy HA. Genetic polymorphism of angiotensin converting enzyme and angiotensin II Type 1 receptors and their impact on the outcome of acute coronary syndrome. Genomics 2020; 112(1): 867–72
  7. Fatini C, Abbate R, Pepe G, Battaglini B, Gensini F, Ruggiano G, et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II Type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J 2000; 21(8): 633–8
  8. Qiu C, Han Z, Lu W. Association of polymorphisms in angiotensin-converting enzyme and Type 1 angiotensin II receptor genes with coronary heart disease and the severity of coronary artery stenosis. J Huazhong Univ Sci Tech Med Sci 2007; 27(6): 660–3
  9. Wu CH, Mohammadmoradi S, Chen JZ, Sawada H, Daugherty A, Lu HS. Renin-angiotensin system and cardiovascular functions. Arterioscler Thromb Vasc Biol 2018; 38(7): e108–16
  10. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019; 40(2): 87–165
  11. Taylor CA, Gaur S, Leipsic J, Achenbach S, Berman DS, Jensen JM, et al. Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractiona